Comparison of Tumor Non-specific and PD-L1 Specific Imaging by Near-Infrared Fluorescence/Cerenkov Luminescence Dual-Modality In-situ Imaging
Background Labeled antibodies are excellent imaging agents in oncology to non-invasively visualize cancer-related antigens expression levels. However, tumor tracer uptake (TTU) of specific antibodies in-vivo may be inferior to non-specific IgG in some cases. Objectives To explore factors affecting l...
Saved in:
Main Authors: | Linhan Zhang MD, Lianmeng Zhao MS, Xue Lin MD, Sheng Zhao MD, Wenbin Pan MS, Dandan Wang MD, Zhongqi Sun MD, Jinping Li MD, Zonghui Liang MD, Rongjun Zhang MS, Huijie Jiang MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-06-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.1177/15353508241261473 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantification of Cerenkov Luminescence Imaging (CLI) Comparable With 3-D PET Standard Measurements
by: Frezghi Habte PhD, et al.
Published: (2018-07-01) -
Intraoperative Imaging of Positron Emission Tomographic Radiotracers Using Cerenkov Luminescence Emissions
by: Jason P. Holland, et al.
Published: (2011-05-01) -
Intraoperative Imaging of Positron Emission Tomographic Radiotracers Using Cerenkov Luminescence Emissions
by: Jason P. Holland, et al.
Published: (2011-05-01) -
Development of [F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide
by: Wojciech G. Lesniak PhD, et al.
Published: (2019-06-01) -
Classification of Acute Coronary Syndrome From a Therapeutic Perspective
by: Cesar Rodrigo Zoni, MD, et al.
Published: (2025-02-01)